177Lu-TATE-EB-01 (LNC1010)

Lutetium-177-labeled TATE-EB-01

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 177Lu-TATE-EB-01 (LNC1010), covering 2025-03-25 to 2025-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of 177Lu-TATE-EB-01（LNC1010）in SSTR2-positive Tumors [Phase 1, Phase 2]